Immunocore Holdings plc (IMCR) Bundle
Immunocore Holdings Reports -4.49 Percent ROIC Outperforming Several Biotech Peers
Immunocore Holdings plc (NASDAQ:IMCR) reported a Return on Invested Capital (ROIC) of -4.49% as of Dec 22, 2025. This figure remains below the company Weighted Average Cost of Capital (WACC) of 6.55%.
The current financial metrics result in a ROIC to WACC ratio of -0.68. This indicates the company is not yet generating returns above its cost of capital despite showing relative efficiency.
Compared to industry peers, Immunocore maintains a stronger capital utilization position than several competitors. The comparative data for the sector includes:
- Vor Biopharma Inc. (VOR) reported a ROIC of -232.79% and a ROIC to WACC ratio of -24.95.
- Cullinan Therapeutics, Inc. (CGEM) recorded a ROIC to WACC ratio of -11.508.
- Sana Biotechnology, Inc. (SANA) posted a ROIC to WACC ratio of -6.208.
- Design Therapeutics, Inc. (DSGN) showed a ROIC to WACC ratio of -3.055.
Immunocore Holdings plc focuses on developing T cell receptor-based therapeutics for cancer, infectious diseases, and autoimmune conditions. Further details regarding the company strategy are available in the IMCR-mission-vision and the IMCR-history-mission-ownership reports.
The company maintains a relatively strong position with potential for improvement in capital utilization. Additional financial analysis can be found in the IMCR-financial-health and IMCR-investor-profile documentation.
Immunocore Holdings plc (IMCR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.